Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays

Bioconjugate Chemistry

Volumn 16, Issue 3, 2005, Pages 559-566

  Geho, David ^a   Lahar, Nicholas ^a   Gurnani, Prem ^c   Huebschman, Michael ^c   Herrmann, Paul ^a   Espina, Virginia ^a   Shi, Alice ^a   Wulfkuhle, Julia ^b   Garner, Harold ^c   Petricoin III, Emanuel ^b   Liotta, Lance A ^a   Rosenblatt, Kevin P ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHIPS; BIOMOLECULES; BIOPSY; HYPERSPECTRAL IMAGING; PROTEINS; SEMICONDUCTOR QUANTUM DOTS; SPECTROSCOPY;

BIOCONJUGATES; CELLULAR LYSATES; KEY NODES; MICROARRAY TECHNOLOGIES; PEGYLATED; PROTEINS MICROARRAYS; PROTEOMICS; QDOT-655; RELATIVE ACTIVITIES; REVERSE PHASIS;

NANOCRYSTALS;

CELL PROTEIN; QUANTUM DOT; STREPTAVIDIN;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; DILUTION CURVE; DRUG CONJUGATION; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; SIGNAL DETECTION; SIGNAL TRANSDUCTION;

EID: 21044448815     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0497113     Document Type: Article

References (26)

1. Liotta, L. A., and Kohn, E. C. (2001) The microenvironment of the tumour-host interface. Nature 411, 375.
2. Hunter, T. (2000) Signaling - 2000 and beyond. Cell 100, 113.
3. Liotta, L. A., Espina, V., Mehta, A. I., Calvert, V., Rosenblatt, K., Geho, D., Munson, P. J., Young, L., Wulfkuhle, J., and Petricoin, E. F., 3rd. (2003) Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 3, 317.
4. Grubb, R. L., Calvert, V. S., Wulkuhle, J. D., Paweletz, C. P., Linehan, W. M., Phillips, J. L., Chuaqui, R., Valasco, A., Gillespie, J., Emmert-Buck, M., Liotta, L. A., and Petricoin, E. F. (2003) Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 3, 2142.
5. Wulfkuhle, J. D., Aquino, J. A., Calvert, V. S., Fishman, D. A., Coukos, G., Liotta, L. A., and Petricoin, E. F., 3rd. (2003) Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3, 2085.
6. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert-Buck, M. R., Roth, M. J., Petricoin, I. E., and Liotta., L. A. (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981.
7. Morozov, V. N., Gavryushkin, A. V., and Deev, A. A. (2002) Direct detection of isotopically labeled metabolites bound to a protein microarray using a charge-coupled device. J. Biochem. Biophys. Methods 51, 57.
8. Wiese, R. (2003) Analysis of several fluorescent detector molecules for protein microarray use. Luminescence 18, 25.
9. Kukar, T., Eckenrode, S., Gu, Y., Lian, W., Megginson, M., She, J. X., and Wu, D. (2002) Protein microarrays to detect protein-protein interactions using red and green fluorescent proteins. Anal. Biochem. 306, 50.
10. Alivisatos, P. (1996) Perspectives on the physical chemistry of semiconductor nanocrystals. J. Phys. Chem. 100, 13226.
11. Alivisatos, P. (2004) The use of nanocrystals in biological detection. Nat. Biotechnol. 22, 47.
12. Bruchez, M., Moronne, M., Gin, P., Weiss, S., and Alivisatos, A. (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281, 2013.
13. Huebschman, M. L., Schultz, R. A., and Garner, H. R. (2002) Characteristics and capabilities of the hyperspectral imaging microscope. IEEE Eng. Med. Biol. Mag. 21, 104.
14. Schultz, R. A., Nielsen, T., Zavaleta, J. R., Ruch, R., Wyatt, R., and Garner, H. R. (2001) Hyperspectral imaging: a novel approach for microscopic analysis. Cytometry 43, 239.
15. Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C., and Liotta, L. A. (2002) Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev. Drug Discovery 1, 683.
16. Espina, V., Mehta, A. I., Winters, M. E., Calvert, V., Wulfkuhle, J., Petricoin, E. F., 3rd, and Liotta, L. A. (2003) Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics 3, 2091.
17. Boise, L. H., and Thompson, C. B. (1997) Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. U.S.A. 94, 3759.
18. Bobrow, M. N., Harris, T. D., Shaughnessy, K. J., and Litt, G. J. (1989) Catalyzed reporter deposition, a novel method of signal amplification application to immunoassays. J. Immunol. Methods 125, 279.
19. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179.
20. Chan, W., Maxwell, D., Gao, X., Bailey, R., Han, M., and Nie, S. (2002) Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 13, 40.
21. Han, M., Gao, X., Su, J. Z., and Nie., S. (2001) Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat. Biotechnol. 19, 631.
22. Watson, A., Wu, X., and Bruchez, M. (2003) Lighting up cells with quantum dots. Biotechniques 34, 296.
23. Xu, Y., and Bao, G. (2003) A filtration-based protein microarray technique. Anal. Chem. 75, 5345.
24. Akerman, M., Chan, W., Laakkonen, P., Bhatia, S., and Ruoslahti, E. (2002) Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. U.S.A. 99, 12617.
25. Ballou, B., Lagerholm, B., Ernst, L., Bruchez, M., and Waggoner, A. (2004) Noninvasive imaging of quantum dots in mice. Bioconjugate Chem. 15, 79.
26. Dabbousi, B. O., Rodriguez-Viejo, J., Mikulec, F. V., Heine, J. R., Mattoussi, H., Ober, R., Jensen, K. F., and Bawendi, M. G. (1997) (CdSe)ZnS core-shell quantum dots: synthesis and characterization of a size series of highly luminescent nanocrystrallites. J. Phys. Chem. B 101, 9463.